Literature DB >> 18575877

Patellar tendon ruptures in weight lifters after local steroid injections.

Shen-Kai Chen1, Cheng-Chang Lu, Pei-His Chou, Lan-Yuen Guo, Wen-Lan Wu.   

Abstract

INTRODUCTION: Weight lifting is commonly associated with an increase in knee injury risk. Local steroid injection is thought to be associated with increased risk of spontaneous tendon rupture. The purpose of this report is to describe incidence of rupture of the patellar tendon after receiving multiple local steroid injections in weight lifters.
MATERIALS AND METHODS: Seven weight lifters presented at the hospital with ruptured patellar tendon. All the patients had a history of multiple local steroid injections into the patellar tendon. Each patient received surgical treatment within 72 h after injury.
RESULTS: After an average follow-up time of 26 months, the mean postoperative Lysholm knee score was 94 and the mean Insall-Salvati measurement was 0.96. All seven athletes returned to weight lifting training at 1 year after the operation. They returned to full competition at 18 months after the surgery.
CONCLUSION: For physicians who treat patellar tendonitis, especially in weight lifters, it is important to recognize the contributing factors for tendon rupture especially in those who have had multiple steroid injections. The functional prognosis of the knee improves if the normal length and strength of the injured tendon have been properly restored.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18575877     DOI: 10.1007/s00402-008-0655-1

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  13 in total

1.  Spontaneous rupture of multiple extensor tendons following repeated steroid injections: a case report.

Authors:  Bing Zhang; Sheng-ting Hu; Ying-ze Zhang
Journal:  Orthop Surg       Date:  2012-05       Impact factor: 2.071

Review 2.  The efficacy, accuracy and complications of corticosteroid injections of the knee joint.

Authors:  James G McGarry; Zubin J Daruwalla
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-01-11       Impact factor: 4.342

3.  Reflections about the optimisation of the treatment of tendinopathies with PRP.

Authors:  Jean-François Kaux; Marc Bouvard; Christelle Lecut; Cécile Oury; André Gothot; Mikel Sanchez; Jean-Michel Crielaard
Journal:  Muscles Ligaments Tendons J       Date:  2015-03-27

Review 4.  [Evidence-based therapy for tendinopathy of the knee joint : Which forms of therapy are scientifically proven?]

Authors:  H Horstmann; J D Clausen; C Krettek; T S Weber-Spickschen
Journal:  Unfallchirurg       Date:  2017-03       Impact factor: 1.000

Review 5.  Extensor mechanism ruptures.

Authors:  Reha N Tandogan; Esref Terzi; Enrique Gomez-Barrena; Bruno Violante; Asim Kayaalp
Journal:  EFORT Open Rev       Date:  2022-05-31

6.  Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome : A prospective randomized study of functional outcomes.

Authors:  M Aksakal; C Ermutlu; G Özkaya; Y Özkan
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

7.  Traumatic extensor hood rupture.

Authors:  Mike J Loosemore; Mark L Ansdell; Charalambos P Charalambous; John W K Harrison; Mike J Hayton
Journal:  Hand (N Y)       Date:  2008-12-19

Review 8.  Adverse effects of extra-articular corticosteroid injections: a systematic review.

Authors:  Aaltien Brinks; Bart W Koes; Aloysius C W Volkers; Jan A N Verhaar; Sita M A Bierma-Zeinstra
Journal:  BMC Musculoskelet Disord       Date:  2010-09-13       Impact factor: 2.362

9.  Fluoroscopically Guided Peritendinous Corticosteroid Injection for Proximal Hamstring Tendinopathy: A Retrospective Review.

Authors:  Luke T Nicholson; Steven DiSegna; Joel S Newman; Suzanne L Miller
Journal:  Orthop J Sports Med       Date:  2014-03-17

Review 10.  Patellar Tendinopathy.

Authors:  Aaron Schwartz; Jonathan N Watson; Mark R Hutchinson
Journal:  Sports Health       Date:  2015-01-23       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.